Free Trial

Coherus BioSciences (CHRS) SEC Filings & 10K Form

Coherus BioSciences logo
$1.07 -0.03 (-2.73%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$1.10 +0.02 (+2.34%)
As of 02/21/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Coherus BioSciences SEC Filings

DateFilerForm TypeView
01/28/2025
4:24 PM
Coherus BioSciences (Filer)
Form DEFM14A
01/22/2025
6:48 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:49 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
6:51 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
4:21 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
3:06 PM
Coherus BioSciences (Filer)
Form PREM14A
01/13/2025
7:45 PM
Coherus BioSciences (Filer)
Form DEFA14A
01/13/2025
3:25 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
7:50 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:51 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
7:52 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:44 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:21 PM
Coherus BioSciences (Filer)
Form DEFA14A
12/03/2024
6:11 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
6:13 AM
Coherus BioSciences (Filer)
Form DEFA14A
11/13/2024
3:30 PM
Coherus BioSciences (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G
11/06/2024
3:23 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
4:15 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
3:39 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:47 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
3:23 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2024
7:14 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
7:16 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2024
7:23 AM
Coherus BioSciences (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
07/02/2024
7:30 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:52 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
5:52 PM
Coherus BioSciences (Issuer)
Newton Charles W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:54 PM
Coherus BioSciences (Issuer)
Erbez Georgia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:55 PM
Coherus BioSciences (Issuer)
Karachun Rita A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/05/2024
5:57 PM
Coherus BioSciences (Issuer)
Karachun Rita A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:45 PM
Coherus BioSciences (Issuer)
O'Donnell-Tormey Jill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:46 PM
Coherus BioSciences (Issuer)
TZOUMAKAS KIMBERLY JO (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:47 PM
Coherus BioSciences (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:49 PM
Coherus BioSciences (Issuer)
STOLPER MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:50 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:51 PM
Coherus BioSciences (Issuer)
Ryan Michael Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
8:11 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
6:27 PM
Coherus BioSciences (Subject)
Temasek Holdings Ltd (0001021944) (Filed by)
Form SC 13G/A
05/21/2024
4:14 PM
Coherus BioSciences (Filer)
Form 8-K/A
05/13/2024
3:35 PM
Coherus BioSciences (Filer)
Form DEFA14A
05/09/2024
3:51 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This Crypto Is Set to Explode in February (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

05/09/2024
6:30 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
4:09 PM
Coherus BioSciences (Filer)
Form DEF 14A
04/15/2024
4:10 PM
Coherus BioSciences (Filer)
Form DEFA14A
04/15/2024
4:11 PM
Coherus BioSciences (Filer)
Form ARS
03/28/2024
3:04 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2024
4:13 PM
Coherus BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
3:16 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:22 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CHRS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners